DLL4 and Ewing sarcoma: In Ewing sarcoma mouse models, it has been demonstrated that inhibition of DLL4 expression results in reduced numbers of bone marrow derived pericytes/ vascular smooth muscle cells (vSMCs) and less functional vessels than tumors of control-treated mice 55.